NCT00216931撤回不适用
Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Oxygenation index
研究概览
简要总结
The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 24 Hours 至 48 Hours（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Elevated arterial pulmonary pressure
- •GA > 24 GW
- •24-48 hours of age
- •Ventilator treatment
排除标准
- •Congenital anomalies
- •Severe hypotension
结局指标
主要结局
Oxygenation index
Cardiac output
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart DiseaseEisenmenger's SyndromePulmonary Arterial HypertensionCongenital Heart DiseaseNCT01319045University of California, Los Angeles5
已完成
不适用
Efficacy of Ventavis Used in Real-life Setting.Pulmonary Arterial HypertensionNCT01355380Bayer55
Unknown
不适用
Imaging Control Study, 3D Echo, MR and RHC.Pulmonary Arterial Hypertension WHO Group INCT02198456Regina Steringer-Mascherbauer12
已完成
3 期
Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)Pulmonary HypertensionNCT01598441Shanghai Jiao Tong University School of Medicine8
尚未招募
不适用
The effect of iloprost on pulmonary hypertension and exercuse capacityPulmonary arterial hypertensionJPRN-UMIN000027284The University of Tokushima Graduate School of Health Biosciences20